Zolmitriptan
Zolmitriptan structure
|
Common Name | Zolmitriptan | ||
|---|---|---|---|---|
| CAS Number | 139264-17-8 | Molecular Weight | 287.357 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 563.3±38.0 °C at 760 mmHg | |
| Molecular Formula | C16H21N3O2 | Melting Point | 136-141ºC | |
| MSDS | Chinese USA | Flash Point | 294.5±26.8 °C | |
| Name | zolmitriptan |
|---|---|
| Synonym | More Synonyms |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 563.3±38.0 °C at 760 mmHg |
| Melting Point | 136-141ºC |
| Molecular Formula | C16H21N3O2 |
| Molecular Weight | 287.357 |
| Flash Point | 294.5±26.8 °C |
| Exact Mass | 287.163391 |
| PSA | 57.36000 |
| LogP | 1.64 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.620 |
| Storage condition | Refrigerator |
| Hazard Codes | Xi: Irritant; |
|---|---|
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| RTECS | RQ2707000 |
| HS Code | 2934999090 |
|
~87%
Zolmitriptan CAS#:139264-17-8 |
| Literature: LABORATORIOS VITA, S. A. Patent: WO2004/14901 A1, 2004 ; Location in patent: Page 18-19 ; |
|
~%
Zolmitriptan CAS#:139264-17-8 |
| Literature: WO2009/44211 A1, ; Page/Page column 17; 22-23 ; |
|
~74%
Zolmitriptan CAS#:139264-17-8 |
| Literature: Aminul, Islam; Chandan, Bhar; Sahadev, Katam Patent: US2005/245585 A1, 2005 ; Location in patent: Page/Page column title page; 9-10; Figure 1 ; |
|
~74%
Zolmitriptan CAS#:139264-17-8 |
| Literature: Aminul, Islam; Chandan, Bhar; Sahadev, Katam Patent: US2005/245585 A1, 2005 ; Location in patent: Page/Page column 8 ; |
|
~46%
Zolmitriptan CAS#:139264-17-8 |
| Literature: Aminul, Islam; Chandan, Bhar; Sahadev, Katam Patent: US2005/245585 A1, 2005 ; Location in patent: Page/Page column 8-9 ; |
|
~%
Zolmitriptan CAS#:139264-17-8 |
| Literature: WO2008/104134 A2, ; Page/Page column title page; 5-7 ; |
|
~%
Zolmitriptan CAS#:139264-17-8 |
| Literature: WO2008/104135 A1, ; Page/Page column 5 ; |
|
~%
Zolmitriptan CAS#:139264-17-8 |
| Literature: US2011/112157 A1, ; |
|
~%
Zolmitriptan CAS#:139264-17-8 |
| Literature: WO2008/104135 A1, ; Page/Page column 4 ; |
![4-[[3-(2-aminoethyl)-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one structure](https://www.chemsrc.com/caspic/165/139264-15-6.png)
![ethyl 3-[2-(dimethylamino)ethyl]-5-[[(4S)-2-oxo-1,3-oxazolidin-4-yl]methyl]-1H-indole-2-carboxylate structure](https://www.chemsrc.com/caspic/398/191864-24-1.png)
| Precursor 8 | |
|---|---|
| DownStream 1 | |
CAS#:139264-69-0| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Bioenhanced sublingual tablet of drug with limited permeability using novel surfactant binder and microencapsulated polysorbate: In vitro/in vivo evaluation.
Eur. J. Pharm. Biopharm. 94 , 386-92, (2015) Formulation of sublingual tablets of drugs with limited permeability poses a great challenge due to their poor absorption. In this study, bioenhanced sublingual tablets (BESTs) of zolmitriptan were pr... |
|
|
Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
PLoS ONE 8(1) , e52683, (2013) Only a limited proportion of patients needing pharmacological control of portal hypertension are hemodynamic responders to propranolol. Here we analyzed the effects of zolmitriptan on portal pressure ... |
|
|
Preparation and evaluation of zolmitriptan submicron emulsion for rapid and effective nasal absorption in beagle dogs.
Drug Dev. Ind. Pharm. 37(12) , 1509-16, (2011) Submicron emulsion was prepared for rapid and effective nasal absorption of zolmitriptan (ZT). The different charge inducers and pH values of the formulations were evaluated to optimize the formulatio... |
| 2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)- |
| BW 311C90 |
| (S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone |
| Zomigoro |
| (4S)-4-({3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one |
| Zolmitriptan |
| Zomigon |
| (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one |
| (S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl]ethylamine |
| AscoTop |
| Zomig |
| MFCD00871503 |